The cloud has become a business imperative today. The pharma industry, though, has been slow off the blocks in transitioning to a cloud operating model. Quite surprisingly, there is a gap between what pharma companies think they need and what they need to succeed on cloud. There might be many reasons for digital transformation taking slower than expected, but cultural change is the root of them all. So how do pharma companies get their cloud journey right?
Find all the answers in this Point of View (PoV) from Matthias Popiolek, our Head of Cloud Consulting, Europe, as he unravels reasons why the cloud conundrum is a challenge for the pharma industry and how they can create a roadmap to maximize business value from cloud.
Benefit from interesting and pragmatic perspectives on:
- The slow pace of cloud adoption in the pharma industry
- Why cultural change can be tough
- Whether to hire cloud expertise or upskill internally
- The Catch-22 of commercial-off-the-shelf applications
- The trust factor with incumbent service providers
- The management buy-in and leading from the front
- Driving proactive change and internal education
- Strengthening the architecture community
- Hexaware’s automation-led approach to cloud transformation
- The amaze® advantage, how it can help with real-life business cases
